Completed
SOS Nutrition Project
NCT01033513
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hyperlipidemia, +6 more
- Locations
-
Not specified
Clinical trial condition
Hyperlipidemia
Explore clinical trials studying Hyperlipidemia. Study availability and eligibility vary by location and protocol.
343 public trials
22 recruiting studies
Hyperlipidemia trial results
NCT00059254
- Conditions
- Body Weight, Diabetes, Diabetes Mellitus, +14 more
- Locations
-
- Utmb Gcrc Galveston, Texas, United States
NCT00382564
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00955903
- Conditions
- Body Weight, Cardiovascular Diseases, Diabetes, +19 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT02428998
- Conditions
- Cardiovascular Diseases, Diabetes, Diabetes Mellitus, +11 more
- Locations
-
- Catholic Universtiy of Korea. Seoul St Mary's Hospital Seoul, South Korea
NCT00090402
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +17 more
- Locations
-
- Oregon Health and Science University Portland, Oregon, United States
NCT00386971
- Conditions
- Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +17 more
- Locations
-
- GCRC UC Davis Sacramento, California, United States
NCT01968954
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Achieve Clinical Research, LLC Birmingham, Alabama, United States
- Cardiovascular Associates of the Southeast, LLC Birmingham, Alabama, United States
- Southwest Heart Group Tucson, Arizona, United States
- ARA-Arizona Research Associates Tucson, Arizona, United States
NCT01131832
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- USDA-ARS, Beltsville Human Nutrition Research Center Beltsville, Maryland, United States
- Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada
Completed
The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production
NCT03141827
- Conditions
- Dyslipidemias, Glucose Metabolism Disorders, Hyperinsulinism, +6 more
- Locations
-
- Tornto General Hospital, UHN Toronto, Ontario, Canada